400 related articles for article (PubMed ID: 20920226)
1. Metabolic syndrome in Russian adults: associated factors and mortality from cardiovascular diseases and all causes.
Sidorenkov O; Nilssen O; Grjibovski AM
BMC Public Health; 2010 Sep; 10():582. PubMed ID: 20920226
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of the metabolic syndrome and its components in Northwest Russia: the Arkhangelsk study.
Sidorenkov O; Nilssen O; Brenn T; Martiushov S; Arkhipovsky VL; Grjibovski AM
BMC Public Health; 2010 Jan; 10():23. PubMed ID: 20085638
[TBL] [Abstract][Full Text] [Related]
3. Impact of age and gender on the prevalence and prognostic importance of the metabolic syndrome and its components in Europeans. The MORGAM Prospective Cohort Project.
Vishram JK; Borglykke A; Andreasen AH; Jeppesen J; Ibsen H; Jørgensen T; Palmieri L; Giampaoli S; Donfrancesco C; Kee F; Mancia G; Cesana G; Kuulasmaa K; Salomaa V; Sans S; Ferrieres J; Dallongeville J; Söderberg S; Arveiler D; Wagner A; Tunstall-Pedoe H; Drygas W; Olsen MH;
PLoS One; 2014; 9(9):e107294. PubMed ID: 25244618
[TBL] [Abstract][Full Text] [Related]
4. Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort.
Guembe MJ; Fernandez-Lazaro CI; Sayon-Orea C; Toledo E; Moreno-Iribas C;
Cardiovasc Diabetol; 2020 Nov; 19(1):195. PubMed ID: 33222691
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with metabolic syndrome in a sample of women in Puerto Rico.
Romaguera J; Ortiz AP; Roca FJ; Colón G; Suárez E
Menopause; 2010 Mar; 17(2):388-92. PubMed ID: 19884863
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of the metabolic syndrome and its relation to cardiovascular disease in an elderly Chinese population.
He Y; Jiang B; Wang J; Feng K; Chang Q; Fan L; Li X; Hu FB
J Am Coll Cardiol; 2006 Apr; 47(8):1588-94. PubMed ID: 16630995
[TBL] [Abstract][Full Text] [Related]
7. The metabolic syndrome predicts cardiovascular mortality: a 13-year follow-up study in elderly non-diabetic Finns.
Wang J; Ruotsalainen S; Moilanen L; Lepistö P; Laakso M; Kuusisto J
Eur Heart J; 2007 Apr; 28(7):857-64. PubMed ID: 17303589
[TBL] [Abstract][Full Text] [Related]
8. The predictive value of metabolic syndrome for cardiovascular and all-cause mortality: Tehran Lipid and Glucose Study.
Amouzegar A; Mehran L; Hasheminia M; Kheirkhah Rahimabad P; Azizi F
Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27155315
[TBL] [Abstract][Full Text] [Related]
9. Prognostic interactions between cardiovascular risk factors.
Vishram JK
Dan Med J; 2014 Jul; 61(7):B4892. PubMed ID: 25123126
[TBL] [Abstract][Full Text] [Related]
10. Relationship between metabolic syndrome and its components and cardiovascular disease in middle-aged and elderly Chinese population: a national cross-sectional survey.
Li W; Song F; Wang X; Wang D; Chen D; Yue W; Zhang H; Wang Z; Lu Z
BMJ Open; 2019 Aug; 9(8):e027545. PubMed ID: 31427317
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk and prevalence of metabolic syndrome by differing criteria.
Li WJ; Xue H; Sun K; Song XD; Wang YB; Zhen YS; Han YF; Hui RT
Chin Med J (Engl); 2008 Aug; 121(16):1532-6. PubMed ID: 18985935
[TBL] [Abstract][Full Text] [Related]
12. Prevalence of ECG abnormalities among adults with metabolic syndrome in a Nigerian Teaching Hospital.
Abiodun A; Oladimeji A; Bamidele T; Adewole A; Mayowa O
Afr Health Sci; 2019 Dec; 19(4):2829-2838. PubMed ID: 32127858
[TBL] [Abstract][Full Text] [Related]
13. Metabolic syndrome in antiphospholipid syndrome versus rheumatoid arthritis and diabetes mellitus: Association with arterial thrombosis, cardiovascular risk biomarkers, physical activity, and coronary atherosclerotic plaques.
Bolla E; Tentolouris N; Sfikakis PP; Tektonidou MG
Front Immunol; 2022; 13():1077166. PubMed ID: 36700208
[TBL] [Abstract][Full Text] [Related]
14. Men in Macau SAR have higher prevalence in metabolic syndrome and among related metabolic components: a cross-sectional Macau Health Survey.
Sobko T; Trindade D; Lao QX; Wong M; Io TK; Wa CK; Gu K
BMC Public Health; 2014 Oct; 14():1065. PubMed ID: 25304760
[TBL] [Abstract][Full Text] [Related]
15. Impact of the metabolic syndrome on mortality from coronary heart disease, cardiovascular disease, and all causes in United States adults.
Malik S; Wong ND; Franklin SS; Kamath TV; L'Italien GJ; Pio JR; Williams GR
Circulation; 2004 Sep; 110(10):1245-50. PubMed ID: 15326067
[TBL] [Abstract][Full Text] [Related]
16. Educational Disparities in Risk for Metabolic Syndrome.
Kim I; Song YM; Ko H; Sung J; Lee K; Shin J; Shin S
Metab Syndr Relat Disord; 2018 Oct; 16(8):416-424. PubMed ID: 29975597
[TBL] [Abstract][Full Text] [Related]
17. Determinants of cardiovascular and all-cause mortality in northwest Russia: a 10-year follow-up study.
Sidorenkov O; Nilssen O; Grjibovski AM
Ann Epidemiol; 2012 Jan; 22(1):57-65. PubMed ID: 21982128
[TBL] [Abstract][Full Text] [Related]
18. Metabolic syndrome and all-cause mortality in older men and women.
Forti P; Pirazzoli GL; Maltoni B; Bianchi G; Magalotti D; Muscari A; Mariani E; Ravaglia G; Zoli M
Eur J Clin Invest; 2012 Sep; 42(9):1000-9. PubMed ID: 22591032
[TBL] [Abstract][Full Text] [Related]
19. Gender differences in changes in metabolic syndrome status and its components and risk of cardiovascular disease: a longitudinal cohort study.
Ramezankhani A; Azizi F; Hadaegh F
Cardiovasc Diabetol; 2022 Nov; 21(1):227. PubMed ID: 36324143
[TBL] [Abstract][Full Text] [Related]
20. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men.
Lakka HM; Laaksonen DE; Lakka TA; Niskanen LK; Kumpusalo E; Tuomilehto J; Salonen JT
JAMA; 2002 Dec; 288(21):2709-16. PubMed ID: 12460094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
